{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:40:42Z","timestamp":1768034442289,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ahj.2015.01.014","type":"journal-article","created":{"date-parts":[[2015,2,21]],"date-time":"2015-02-21T02:04:11Z","timestamp":1424484251000},"page":"713-720.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical benefit of spironolactone in patients with acute decompensated heart failure and severe renal dysfunction: Data from the Korean Heart Failure Registry"],"prefix":"10.1016","volume":"169","clinical-trial-number":[{"clinical-trial-number":"nct01807221","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jaewon","family":"Oh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok-Min","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Kyung","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namki","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Chan","family":"Youn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seongwoo","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Seok","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myeong-Chan","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Su","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shung Chull","family":"Chae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Hee","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Ju","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung-Mook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu-Hyung","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2015.01.014_bb0005","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2015.01.014_bb0010","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2015.01.014_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2015.01.014_bb0020","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0002-8703(03)00189-3","article-title":"Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure","volume":"146","author":"Masoudi","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2015.01.014_bb0025","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1001\/jama.2012.14795","article-title":"Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction","volume":"308","author":"Hernandez","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2015.01.014_bb0030","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ahj.2013.03.007","article-title":"Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure","volume":"165","author":"Curtis","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2015.01.014_bb0035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/CIRCHEARTFAILURE.112.000115","article-title":"Association of spironolactone use with all-cause mortality in heart failure: a propensity scored cohort study","volume":"6","author":"Lund","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2015.01.014_bb0040","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.jacc.2012.07.048","article-title":"Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study)","volume":"60","author":"Vardeny","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2015.01.014_bb0045","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cardfail.2012.02.005","article-title":"Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee","volume":"18","author":"Butler","year":"2012","journal-title":"J Card Fail"},{"key":"10.1016\/j.ahj.2015.01.014_bb0050","article-title":"ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"2013","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2015.01.014_bb0055","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2015.01.014_bb0060","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jacc.2011.10.864","article-title":"Baseline anemia is not a predictor of all-cause mortality in outpatients with advanced heart failure or severe renal dysfunction. Results from the Norwegian Heart Failure Registry","volume":"59","author":"Waldum","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2015.01.014_bb0065","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4070\/kcj.2011.41.7.363","article-title":"Characteristics, outcomes and predictors of long-term mortality for patients hospitalized for acute heart failure: a report from the Korean Heart Failure registry","volume":"41","author":"Choi","year":"2011","journal-title":"Korean Circ J"},{"key":"10.1016\/j.ahj.2015.01.014_bb0070","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijcard.2012.10.054","article-title":"The CKD-EPI is more accurate in clinical outcome prediction than MDRD equation in acute heart failure: data from the Korean Heart Failure (KorHF) Registry","volume":"167","author":"Oh","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2015.01.014_bb0075","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1016\/j.ijcard.2013.07.241","article-title":"Hemoconcentration is a good prognostic predictor for clinical outcomes in acute heart failure: data from the Korean Heart Failure (KorHF) Registry","volume":"168","author":"Oh","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2015.01.014_bb0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ahj.2012.10.009","article-title":"Short- and long-term outcomes depending on electrical dyssynchrony markers in patients presenting with acute heart failure: clinical implication of the first-degree atrioventricular block and QRS prolongation from the Korean Heart Failure registry","volume":"165","author":"Park","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2015.01.014_bb0085","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cardfail.2009.01.002","article-title":"Relation between red cell distribution width with echocardiographic parameters in patients with acute heart failure","volume":"15","author":"Oh","year":"2009","journal-title":"J Card Fail"},{"key":"10.1016\/j.ahj.2015.01.014_bb0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1253\/circj.CJ-11-0664","article-title":"Prognostic value of change in red cell distribution width 1 month after discharge in acute decompensated heart failure patients","volume":"76","author":"Oh","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2015.01.014_bb0095","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D'Agostino","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.ahj.2015.01.014_bb0100","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.athoracsur.2012.05.023","article-title":"The impact of complete revascularization on long-term survival is strongly dependent on age","volume":"94","author":"Girerd","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2015.01.014_bb0105","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/jama.286.10.1187","article-title":"Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: a propensity analysis","volume":"286","author":"Gum","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2015.01.014_bb0110","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1093\/ndt\/gfm349","article-title":"Why we should sub-divide CKD stage 3 into early (3a) and late (3b) components","volume":"22","author":"Abutaleb","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ahj.2015.01.014_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jacc.2012.08.1019","article-title":"Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction","volume":"61","author":"Rassi","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2015.01.014_bb0120","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.jacc.2013.04.086","article-title":"Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and\/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)","volume":"62","author":"Eschalier","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2015.01.014_bb0125","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/eurjhf\/hft011","article-title":"Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care","volume":"15","author":"Gjesing","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2015.01.014_bb0130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jacc.2011.01.052","article-title":"Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure","volume":"58","author":"Testani","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2015.01.014_bb0135","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00392-009-0025-1","article-title":"Elevated blood urea nitrogen-to-creatinine ratio increased the risk of hospitalization and all-cause death in patients with chronic heart failure","volume":"98","author":"Lin","year":"2009","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ahj.2015.01.014_bb0140","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/eurjhf\/hfr123","article-title":"Influence of renal dysfunction phenotype on mortality in the setting of cardiac dysfunction: analysis of three randomized controlled trials","volume":"13","author":"Testani","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2015.01.014_bb0145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/CIRCHEARTFAILURE.112.968230","article-title":"Blood urea nitrogen\/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure","volume":"6","author":"Brisco","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2015.01.014_bb0150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2015.01.014_bb0155","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0140-6736(11)61126-4","article-title":"The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial","volume":"378","author":"Cleland","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2015.01.014_bb0160","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurjhf\/hft100","article-title":"Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial","volume":"15","author":"Girerd","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2015.01.014_bb0165","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2015.01.014_bb0170","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jchf.2012.08.001","article-title":"Aldosterone antagonists and outcomes in real-world older patients with heart failure and preserved ejection fraction","volume":"1","author":"Patel","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ahj.2015.01.014_bb0175","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2013.905","article-title":"Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial","volume":"309","author":"Edelmann","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2015.01.014_bb0180","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2015.01.014_bb0185","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejim.2013.08.711","article-title":"Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure","volume":"25","author":"Ferreira","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ahj.2015.01.014_bb0190","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ahj.2010.04.024","article-title":"Effect of eplerenone versus spironolactone on cortisol and hemoglobin A(1)(c) levels in patients with chronic heart failure","volume":"160","author":"Yamaji","year":"2010","journal-title":"Am Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870315001106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870315001106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:54:37Z","timestamp":1757570077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870315001106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0002870315001106"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2015.01.014","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical benefit of spironolactone in patients with acute decompensated heart failure and severe renal dysfunction: Data from the Korean Heart Failure Registry","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2015.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}